A recent report published by the American Lung Association shows that only a tiny fraction of Americans that are eligible…
The financing initiatives underscore a disciplined approach to capital management at a critical stage for Soligenix. The company’s leadership has…
Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the clinical advancement of HyBryte(TM) (synthetic…
The company revealed the trial at the Australia Translational Breast Cancer Research Symposium (“ATBCR”) Sapu-003 is an injectable formulation of…
Approximately 20% of people in the U.S. live in a rural area, and they face unique health challenges, such as…
On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant of $37.5 million targeting HCIDs…
Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer. It resists existing treatments and…
Thermostable vaccine technology is considered a significant unmet need in epidemic preparedness. Soligenix has been developing formulations intended to remain…
Many existing cancer treatments, such as chemotherapy and radiation, don’t distinguish between cancer cells and healthy body cells, and the…
A study whose findings were recently published has provided insights into the cost of treating injuries resulting from firearms, with…